Skip to content

Pharmacokinetic Models

ROCKETSHIP fits tracer kinetic models to the contrast agent concentration curves produced by the signal to concentration conversion. This section gives the equations for each available model, the parameters it estimates, and guidance on when it is the appropriate choice.

Any number of models may be enabled for a single run. Each produces its own set of parameter maps and its own results file, which allows several models to be compared on the same data.

Primary reference

For a thorough treatment of these models, their underlying assumptions and the reasoning behind choosing between them, refer to:

Sourbron, S.P. and Buckley, D.L. Classic models for dynamic contrast-enhanced MRI. NMR in Biomedicine, 26(8), 1004-1027 (2013).

It is the standard reference on the subject and covers the material below in considerably more depth than these pages can. Users selecting a model for a new study, or needing to justify that choice, should start there.

Common formulation

With the exception of the area under the curve summary measure, every model describes the tissue concentration \(C_t(t)\) as the convolution of the arterial plasma concentration \(C_p(t)\) with an impulse response function \(h(t)\) characteristic of the model:

\[ C_t(t) = \bigl(C_p * h\bigr)(t) = \int_{0}^{t} C_p(\tau)\, h(t - \tau)\, \mathrm{d}\tau \]

Fitting a model means finding the parameters of \(h\) that best reproduce the measured \(C_t(t)\) in the least squares sense. The models differ in how many compartments they describe and which physiological processes they treat as rate limiting.

Parameters

The same symbols recur throughout this section.

Symbol Name Units Interpretation
\(K^{trans}\) Volume transfer constant min\(^{-1}\) Rate of contrast agent transfer from plasma to extravascular extracellular space
\(v_e\) Extravascular extracellular volume fraction Fraction of tissue volume accessible to contrast agent outside cells and vessels
\(v_p\) Plasma volume fraction Fraction of tissue volume occupied by plasma
\(F_p\) Plasma flow min\(^{-1}\) Plasma perfusion per unit tissue volume
\(PS\) Permeability surface area product min\(^{-1}\) Capillary wall permeability times surface area per unit volume
\(k_{ep}\) Efflux rate constant min\(^{-1}\) \(K^{trans}/v_e\), the rate of return from tissue to plasma
\(T_p\) Plasma mean transit time min Mean residence time in the plasma compartment
\(T_e\) Extravascular mean transit time min Mean residence time in the extravascular space
\(E\) Extraction fraction \(K^{trans}/F_p\), the fraction of arriving tracer extracted in one pass
\(\tau_i\) Intracellular water lifetime min Mean time a water molecule spends inside a cell

Choosing a model

The models form a hierarchy. More parameters allow a closer description of the underlying physiology, but each additional parameter requires more information from the data to constrain it. Temporal resolution, signal to noise ratio and the duration of the acquisition all determine how much a given dataset can support.

The summary below is intended to orient the choice, not to settle it. The assumptions behind each model, the conditions under which they hold, and the consequences of applying a model outside them are set out in detail by Sourbron and Buckley (2013).

Model Parameters Assumes Typical use
Tofts \(K^{trans}\), \(v_e\) Negligible intravascular contribution Weakly vascularized tissue; the historical standard
Extended Tofts \(K^{trans}\), \(v_e\), \(v_p\) Rapid plasma equilibration Well vascularized tumors; the most widely used model
Patlak \(K^{trans}\), \(v_p\) Negligible backflux Low permeability tissue, most used for blood–brain barrier integrity
Tissue Uptake \(K^{trans}\), \(F_p\), \(T_p\) Negligible backflux, finite flow Separating flow from permeability over a short acquisition
Two-Compartment Exchange \(K^{trans}\), \(v_e\), \(v_p\), \(F_p\) Two well mixed compartments High temporal resolution data where flow and permeability are separable
FXR \(K^{trans}\), \(v_e\), \(\tau_i\) Finite transcytolemmal water exchange Where the fast exchange assumption is questionable
Area Under the Curve AUC, NAUC No kinetic model Model-free summary; robust where fitting is unreliable

Beware of more complicated models

A more complicated model frequently gives worse accuracy in the fitted parameters. The additional degrees of freedom fit noise rather than signal, which increases the uncertainty on every parameter estimated.

Measurement of low \(K^{trans}\) values at the blood–brain barrier is a clear example. The two-parameter Patlak model has been shown to give the most accurate results there, despite being the simplest of the leakage models:

The most complex model a given dataset will support can be determined empirically. The MATLAB analysis stage provides Akaike information criterion, F test and FMI/FRI comparisons between fitted models on the same regions of interest; see the DCE walkthrough.

Numerical implementation

Several implementation choices apply across the model set:

  • Convolution. Each model's convolution integral is evaluated by a recurrence that carries the running total forward from one timepoint to the next, instead of re-integrating the whole curve at every timepoint. Fitting cost (time) therefore grows in proportion to the number of timepoints, rather than with its square, this provides a large speed up. Within each sampling interval the curve is integrated by the trapezoid rule.

    How the recurrence works

    Each model needs an integral running from the start of the acquisition up to every timepoint \(t_k\), of the form

    \[ \int_{0}^{t_k} C_p(\tau)\, e^{-\lambda (t_k - \tau)}\,\mathrm{d}\tau \]

    A running total cannot be accumulated directly, because the weight \(e^{-\lambda(t_k - \tau)}\) depends on the endpoint \(t_k\): moving to the next timepoint changes the weight applied to every earlier sample.

    The exponential separates, however:

    \[ e^{-\lambda(t_k - \tau)} = e^{-\lambda \Delta t}\; e^{-\lambda(t_{k-1} - \tau)}, \qquad \Delta t = t_k - t_{k-1} \]

    so the integral already accumulated up to \(t_{k-1}\) becomes correct for \(t_k\) after multiplication by the single factor \(e^{-\lambda \Delta t}\). Each timepoint then costs one rescaling of the running total plus the contribution of the newest interval, which is a fixed amount of work regardless of how much history precedes it.

    The rescaling is exact. The approximation lies in the trapezoid rule applied within each interval, and its error is governed by the temporal resolution of the acquisition.

  • Fitting. Parameters are estimated by bound-constrained nonlinear least squares. Initial values and bounds are configurable per parameter and per model; see the DCE Options reference.

  • Confidence intervals. Ninety-five percent confidence intervals are derived from the covariance of the converged fit and reported alongside each parameter.
  • Acceleration. The Tofts, extended Tofts, Patlak, tissue uptake and two-compartment exchange models have accelerated implementations that run on GPU or multi-core CPU. See GPU and CPU Acceleration.

Units

Rate constants are reported per minute and volume fractions are dimensionless. Where the supplied time vector is in seconds, fitting is still carried out internally in minutes and the returned rate parameters are converted back to match the units of the input time vector.

References

Sourbron, S.P. and Buckley, D.L. Classic models for dynamic contrast-enhanced MRI. NMR in Biomedicine, 26(8), 1004-1027 (2013).

Sourbron, S.P. and Buckley, D.L. Tracer kinetic modelling in MRI: estimating perfusion and capillary permeability. Physics in Medicine and Biology, 57(2), R1-R33 (2012).

Sourbron, S.P. and Buckley, D.L. On the scope and interpretation of the Tofts models for DCE-MRI. Magnetic Resonance in Medicine, 66(3), 735-745 (2011).

Tofts, P.S., et al. Estimating kinetic parameters from dynamic contrast-enhanced T1-weighted MRI of a diffusable tracer: standardized quantities and symbols. Journal of Magnetic Resonance Imaging, 10(3), 223-232 (1999).

Barnes, S.R., et al. Optimal acquisition and modeling parameters for accurate assessment of low Ktrans blood-brain barrier permeability using dynamic contrast-enhanced MRI. Magnetic Resonance in Medicine, 75(5), 1967-1977 (2016).

Cramer, S.P. and Larsson, H.B.W. Accurate determination of blood-brain barrier permeability using dynamic contrast-enhanced T1-weighted MRI: a simulation and in vivo study on healthy subjects and multiple sclerosis patients. Journal of Cerebral Blood Flow and Metabolism, 34(10), 1655-1665 (2014).

References specific to each model are listed on its own page.